980
Participants
Start Date
February 2, 2017
Primary Completion Date
December 30, 2017
Study Completion Date
December 30, 2017
Budesonide/Formoterol treated patients
patients who are eligible to start their treatment with budesonide/formoterol therapy
7th Pulmonary Dept, Athens Chest Hospital, Athens
Lead Sponsor
Elpen Pharmaceutical Co. Inc.
INDUSTRY